Bioxytran Inc (BIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 1,933 | 607 | 496 | 224 | 515 |
| Operating Income | -1,933 | -607 | -496 | -224 | -515 |
| Interest Expense | 61 | 62 | 47 | 45 | 32 |
| Other Income | -75 | 147 | 261 | 305 | -807 |
| Pre-tax Income | -2,069 | -522 | -283 | 35 | -1,354 |
| Net Income Continuous | -2,069 | -522 | -283 | 35 | -1,354 |
| Net Income | $-2,069 | $-522 | $-283 | $35 | $-1,354 |
| EPS Basic Total Ops | -0.02 | N/A | 0.00 | 0.00 | -0.02 |
| EPS Basic Continuous Ops | -0.02 | -0.01 | 0.00 | 0.00 | -0.02 |
| EPS Diluted Total Ops | -0.02 | N/A | 0.00 | 0.00 | -0.02 |
| EPS Diluted Continuous Ops | -0.02 | -0.01 | 0.00 | 0.00 | -0.02 |
| EPS Diluted Before Non-Recurring Items | -0.02 | 0.00 | 0.00 | 0.00 | -0.02 |
| EBITDA(a) | $-1,931 | $-604 | $-492 | $-222 | $-513 |